-
781por Stockman, Leah S., Gundersen, Daniel A., Gikandi, Ajami, Akindele, Ruth N., Svoboda, Ludmila, Pohl, Sarah, Drews, Mark R., Lathan, Christopher S.“…Integrating specialized cancer care services within community settings is important for addressing the needs of historically marginalized populations. Our National Cancer Institute–Designated Cancer Center initiated a clinical outreach program incorporating cancer diagnostic services and patient navigation within a Federally Qualified Health Center (FQHC) to expedite evaluation and resolution of potential cancer diagnoses with the goal of collaboration between oncology specialists and primary care providers in a historically marginalized community in Boston, MA. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
782por Hafez, Nora, Refaat, Lobna, ElGebaly, Omnia K., Elhariry, Hossam M., Ghareeb, Mohammed, Fathalla, Lamiaa A.“…PATIENTS AND METHODS: The present study included 44 denovo Myeloma patients, recruited from the Medical Oncology Department, National Cancer Institute, Cairo University. Detection of RGS1 and mTOR expression was performed using Immunohistochemical staining on bone marrow biopsy sections. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
783por Edward, Jean S., McLouth, Laurie E., Rayens, Mary Kay, Eisele, Lori P., Davis, Tani S., Hildebrandt, Gerhard“…METHODS: All patients who presented to the Division of Hematology and Bone and Marrow Transplant (BMT) at an National Cancer Institute–designated cancer center between April 2021 and January 2022 were screened for FT during inpatient and outpatient visits. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
784por Jurkevičiūtė, Dignė, Mauravičiūtė, Sandra, Dulskas, Audrius, Kildušienė, Inga, Stratilatovas, Eugenijus, Jarmalaitė, Sonata“…METHODS: A retrospective analysis was performed using the database of the National Cancer Institute, Lithuania. We have divided patients into two groups: group 1 – patients treated during the nonpandemic period (2019 January 1 to 2019 July 31) and group 2 – the pandemic period (2020 January 1 to 2020 July 31). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
785Improvement in radiation techniques for locally advanced cervical cancer during the last two decadespor Sagae, Satoru, Toita, Takafumi, Matsuura, Motoki, Saito, Manabu, Matsuda, Takuma, Sato, Nanaka, Shimizu, Ayumi, Endo, Toshiaki, Fujii, Miho, Gaffney, David K, Small, William“…Since the National Cancer Institute (NCI) alert of concurrent chemoradiotherapy, radiotherapy has been changed from external beam radiotherapy plus brachytherapy to platinum-based concurrent chemoradiotherapy. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
786por Wang, Jixin, Yu, Wen, D’Anna, Rachel, Przybyla, Anna, Wilson, Matt, Sung, Matthew, Bullen, John, Hurt, Elaine, D’Angelo, Gina, Sidders, Ben, Lai, Zhongwu, Zhong, Wenyan“…The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) provides unique opportunities for cancer target discovery using protein expression. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
787por Mizusawa, Junki, Sato, Hioryuki, Rubinstein, Larry V., Fujiwara, Takeo, Yonemori, Kan, Hirakawa, Akihiro“…METHODS: Early‐phase clinical trials sponsored by the Cancer Therapy Evaluation Program at the National Cancer Institute, USA, that evaluated cytotoxic drugs and molecularly targeted agents between March 2000 and December 2012 were studied. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
788por Theerawatanasirikul, Sirin, Lueangaramkul, Varanya, Pantanam, Achiraya, Mana, Natjira, Semkum, Ploypailin, Lekcharoensuk, Porntippa“…Herein, we utilized computer-aided, structure-based virtual screening to filter lead compounds from the National Cancer Institute (NCI) diversity and mechanical libraries using FMDV 3C protease (3C(pro)) as the target. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
789por Jiang, Yanting, Wang, Yiqi, Cheng, Xiaofei, Zhou, Ziyang, Wang, Jili, Yu, Haogang, Yao, Guorong, Lu, Zhongjie, Chen, Xin, Yan, Senxiang, Zhao, Feng“…METHODS: This was a retrospective, population-based cohort study that followed patients with FPC and SPC diagnosed from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) 17 registries database between 1 January 2000 and 31 December 2019. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
790por Anderson, Ashley B., Park, Amie B., Zhu, Kangmin, Lin, Jie, Shriver, Craig D., Potter, Benjamin K.“…US population data were obtained from the National Cancer Institute's Surveillance, Epidemiology, and End Results registry. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
791The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoringpor Batool, Syeda Maheen, Yekula, Anudeep, Khanna, Prerna, Hsia, Tiffaney, Gamblin, Austin S., Ekanayake, Emil, Escobedo, Ana K., You, Dong Gil, Castro, Cesar M., Im, Hyungsoon, Kilic, Tugba, Garlin, Michelle Andrea, Skog, Johan, Dinulescu, Daniela M., Dudley, Jonathan, Agrawal, Nishant, Cheng, Jordan, Abtin, Fereidoun, Aberle, Denise R., Chia, David, Elashoff, David, Grognan, Tristan, Krysan, Kostyantyn, Oh, Scott S., Strom, Charles, Tu, Michael, Wei, Fang, Xian, Rena R., Skates, Steven J., Zhang, David Y., Trinh, Thi, Watson, Mark, Aft, Rebecca, Rawal, Siddarth, Agarwal, Ashutosh, Kesmodel, Susan B., Yang, Changhuei, Shen, Cheng, Hochberg, Fred H., Wong, David T.W., Patel, Abhijit A., Papadopoulos, Nickolas, Bettegowda, Chetan, Cote, Richard J., Srivastava, Sudhir, Lee, Hakho, Carter, Bob S., Balaj, Leonora“…We specifically focus on the technical and clinical challenges associated with liquid biopsy and biomarker development being addressed by the Liquid Biopsy Consortium, established through the National Cancer Institute. The Liquid Biopsy Consortium has developed new methods/assays and validated existing methods/technologies to capture and characterize tumor-derived circulating cargo, as well as addressed existing challenges and provided recommendations for advancing biomarker assays.…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
792por Foucaud, J“…In 2010, the French National Cancer Institute was a pioneer in the development of PHIR in France and decided in 2021 to make it one of the spearheads of its ten-year strategy. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
793por Ahsan, Habibul, Whittemore, Alice S, Chen, Yu, Senie, Ruby T, Hamilton, Steven P, Wang, Qiao, Gurvich, Irina, Santella, Regina M“…These nuclear families were selected from breast cancer families participating in the Metropolitan New York Registry, one of the six centers of the National Cancer Institute's Breast Cancer Family Registry. …”
Publicado 2005
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
794por Gonçalves, Débora Silva, dos Santos, Arn Migowski Rocha, da Costa, Susanne Crocamo Ventilari, da Costa, Rodrigo Saar, Senna, Katia Marie Simões e, Zimmermann, Ivan Ricardo“…METHODS: This is a retrospective cohort, based on data from computerized medical records from one of the units of the National Cancer Institute (INCA), in Rio de Janeiro-RJ, Brazil. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
795por Altinok Dindar, Duygu, Chun, Brie, Palma, Amy, Cheney, John, Krieger, Madeline, Kasschau, Kristin, Stagaman, Keaton, Mitri, Zahi I., Goodyear, Shaun M., Shannon, Jackilen, Karstens, Lisa, Sharpton, Thomas, Zhang, Zhenzhen“…Comprehensive patient data was collected, including dietary habits assessed through the National Cancer Institute Diet History Questionnaire (DHQ). 16S rRNA amplicon sequencing was used to analyze gut microbiome composition and assess alpha and beta diversity. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
796“…Using a carefully curated library of 4533 compounds provided by the National Cancer Institute, Bethesda, MD, USA, we identified mitoxantrone as a potent TET agonist. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
797por Benedetti, Elisa, Chetnik, Kelsey, Flynn, Thomas, Barbieri, Christopher E., Scherr, Douglas S., Loda, Massimo, Krumsiek, Jan“…The Early Detection Research Network (EDRN) is a consortium within the National Cancer Institute aimed at improving screening approaches and early detection of cancers. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
798por Arefpour, Amir Mohammad, Hosseini, Saeed, Basi, Ali, Novin, Kambiz, Foroughi, Ahmad, Garousi, Maryam“…Also, the side effects were classified according to the National Cancer Institute Common Toxicity Criteria for Adverse Events (CTCAE) version 5.0. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
799“…The cell strains were obtained from the discarded tissues through the Cooperative Human Tissue Network (sponsors: National Cancer Institute and National Disease Research Interchange). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
800por Gold, L S, Manley, N B, Slone, T H, Garfinkel, G B, Ames, B N, Rohrbach, L, Stern, B R, Chow, K“…Analyses are included on 17 chemicals tested in nonhuman primates by the Laboratory of Chemical Pharmacology, National Cancer Institute. This plot presents results of 531 long-term, chronic experiments of 182 test compounds and includes the same information about each experiment in the same plot format as the earlier papers: the species and strain of test animal, the route and duration of compound administration, dose level and other aspects of experimental protocol, histopathology and tumor incidence, TD50 (carcinogenic potency) and its statistical significance, dose response, author's opinion about carcinogenicity, and literature citation. …”
Publicado 1995
Enlace del recurso
Enlace del recurso
Texto